October 2020 - 4D Lifetec files new patent for its cancer biomarker DNA Damage Sensitivity (DDS)

4D Lifetec has filed a patent application for its powerful cancer biomarker DDS to make it part of its proprietary technology. This biomarker has clinically proven its efficacy for the early detection of cancer and is part of the liquid biopsy assay 4D Lifetest™. It is the fourth patent in total with which 4D Lifetec has protected its technology worldwide. Some of these patents have already been granted in various countries.